Juvenescence CEO on near-term Longevity breakthroughs

We talk pipeline, trials, raising capital and public company challenges with Juvenescence’s Dr Greg Bailey. Longevity.Technology: Longevity is growing as a distinct investment category and Thursday’s session at next week’s Longevity 2020 online conference addresses the current state of anti-aging investment. One of the speakers in this session is Dr Greg Bailey, CEO of biopharmaceutical company … Continue reading Juvenescence CEO on near-term Longevity breakthroughs